http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-276599-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1998-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4344680661b54f7869229ade3c6fc53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89072ab05621bf4a23e6bdedfd5ed62c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ad66f65941b7e0c0b54397245d136b
publicationDate 2000-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-276599-A3
titleOfInvention A method for crystallizing an inhibitor
abstract The instant invention describes a method for crystallizing (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one from a solvent and anti-solvent solvent system and producing the crystalline product. The desired final crystal form, Form I, can be produced when using methanol or ethanol. Form II is isolated from 2-propanol and can be converted to the desired crystal form at low drying temperatures, such as between about a temperature of 40 DEG C and 50 DEG C.
priorityDate 1997-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428288747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70680434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422138360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140985477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454066185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19937448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451907885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21263495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418449727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836

Total number of triples: 53.